Investor Alert - Medical Marijuana Inc. MJNA Cannot Sell

New Post Public Reply Private Reply Replies (0) Message Board
cb11
Investor Alert - Medical Marijuana Inc. MJNA Cannot Sell !!



Cannabis · Hemp · Hanf · Cannabinoids · THC · CBD · Medical · Medicinal ·

FDA · NHI · EMA · JMA · Patient · Patent · License · Audit · Report · SEC ·



MMJ = Medical Marijuana or CBD Hemp !



Medical Marijuana Inc. - Cannot Sell MMJ or CBD Products !!



Seems majority of its Investors mentally very

dependent, that normal commonsense market

considerations are not possible. Just Pumpers

fake oriented !

For example most of them like to believe, that

Registered MMJ or CBD Patients for Pain-Therapy

will pay annually about $ 8000.- to MJNA, when

they at any Pharmacy as even FDA Approved can

get for $ ZERO the principally much more expensive

CBD Sativex which is also killing Pain & Cancer as

it already worldwide does, but FDA Approved the

US Health Insurances completely paying for it !!



100% sure, 99% of Registered Patients are not

willing to pay annually $ 8000.- to MJNA as they

don’t need or not even have the money or with

that money better go for Holiday or do with it

something else in life important, instead of

paying for Companies such as MJNA !



Famous CBD Sativex is now at every Pharmacy available !!!



MJNA at present has the most exposure and

because of this it gets most affected, but for

fairness its necessary to mention that any MJ

Company with desire to sell MMJ Products get

affected by its None FDA Approved Products

the US Health Insurances Therefore Not Pay !!

MJNA is additionally under SEC Investigations.



Small US MJ Companies not able to change

the Handling of the US Health Insurances !!



This for All Investors to think very well about !



PS : GW Pharmaceuticals the producer of its

patented Sativex, by its owner consortium is

related to Big Global Player Companies with

worldwide annual Revenue of about $ 168 Bn.

This only for knowing with what the small US

MJ Companies really dealing with and to see

the present situation as the beginning only !

For the additional Wellness- Products, there

will be coming Companies as Nestle, Unilever,

RedBull, Etc. also to keep well in mind !!

Its not that simple or easy as Pumpers Think !

Additionally New Fed. US MJ Laws to expect,

will KILL MJ THC Content Wellness Products !



MJNA’s “Cibaderm” is a Big Global Player NOVARTIS Brand ; Happy Lawsuits !!

According evidences MJNA Insisting on the Very Old Well Known Brand !



Additionally as known the SEC knocking at MJNA Doors !!

They Call That Inquiry When Doing Investigations ¨!!!



This With Compliments By On2_addict Presented.





As Investor if you may get or got harmed by any Short- Talk Blackmailing

or Misleading MB Members, just add www. to the Posts- Link to send and

File your Claims at ic3.gov CIA & FBI Branch - Internet Crimes, they help !



By The Company Abused, Mislead, Etc. ; Contact SEC Washington

To File Your Claims To Get Compensated !!

SEC Washington Hotline 202 551-6551 - Investors Protection

SEC Office Whistleblower at
Scroll down for more posts ▼

Top 10 Most Recent News Articles

M&A Source's 2026 Conference Tackles Deal-Making Drama

Updated Category News Views 84

High Stakes and Deep Insights Await in Houston Cracking the nut of lower-middle market transactions ain’t a walk in the park. M&A Source®'s Fall 2026 Conference is gearing up to address the very dramas that lurk behind the scenes. Kicking off November 2-4 at the opulent JW Marriott in Houston, Texas, the event is looking to assemble a heavyweight lineup of...

Continue Reading
Co-Diagnostics Nearing India TB Test Launch By 2026

Updated Category News Views 98

Co-Diagnostics Gears Up for Indian TB Test Market Picture this: Co-Diagnostics, a molecular diagnostics player, is on the brink of a significant leap toward expanding its footprint in India with its TB test. The stage is set, with a clinical study already turning in results as solid as old boots. We're talking sensitivity hovering around 97.3% and specificity at...

Continue Reading
Tamara Toles O'Laughlin: Steering Philanthropy's Next Era

Updated Category News Views 52

Leadership Transition in Philanthropy Everyone knows the drill: leadership changes are often a toss-up. You could get a fresh burst of energy or spend years longing for the good old days. That's where The New York Women's Foundation finds itself as they hand over the reins from Ana L. Oliveira to Tamara Toles O'Laughlin. In a world where philanthropic shifts can either...

Continue Reading
Fairfax Crest: A New Chapter in Affordable Housing

Updated Category News Views 31

Setting the Stage: Fairfax Crest's Grand Opening You know what's better than leaving a dusty old car park underutilized? Turning it into homes for folks who really need them. That's exactly what went down in Fairfax County as they cut the ribbon on their latest affordable housing project, Fairfax Crest. We're talking 279 affordable units sprouting up where there once lay...

Continue Reading
Hisense's AI S7 Dishwasher Revolutionizes Home Living

Updated Category News Views 75

The Intersection of AI and Home Appliances In a world where families are looking for more efficiency, Hisense isn’t just tossing another dishwasher into the wild. No, they're aiming to redefine the whole damn experience of household chores with their latest brainchild, the Hisense S7 Dishwasher. Packed with AI smarts and an impressive tech bouquet, this bad boy is all...

Continue Reading
Personalis Merger Faces Investigation: $16.25 Offers Scrutinized

Updated Category News Views 38

Market Storm or Light Drizzle? When the sharks smell blood or the legal eagles start circling, you know something stinks. BFA Law is sniffing around, and it isn’t just for sport. They’re putting their magnifying glass on this curious $16.25 per share transaction where Tempus AI plans to gobble up Personalis lock, stock, and barrel. For investors holding NASDAQ:PSNL,...

Continue Reading
XCMG Climbs Fortune China 500: Strengthens Global Edge

Updated Category News Views 83

XCMG's Ascent on the Fortune China 500 When it comes to scaling new heights, XCMG Machinery is clearly in the driver's seat, roaring up the Fortune China 500 to claim the 202nd spot, leaping ten ranks from last year. While others may coast, XCMG's trajectory is anything but idle, retaining its crown among Chinese construction machinery titans. The recent summit in Chengdu...

Continue Reading
Common Thread Advisors: Transforming Change in Business

Updated Category News Views 41

Navigating the Storm of Change: A New Player in Town You know, just when you think you've got the business world figured out, something sharp comes along. Today, it’s Common Thread Advisors, making its grand entrance to help organizations steer through the dense fog of change. This isn’t your everyday, run-of-the-mill consultancy. No sir, they’re out here with a...

Continue Reading
Bybit’s Gold Yield Offer: 2.83% APR on XAUT

Updated Category News Views 74

Gold Savings with a Tokenized Twist Taking a wild swing at pairing gold and crypto in a digestible package, Bybit and the XAUE Protocol have teamed up to offer a 2.83% fixed APR on XAUT Savings. If you're itching for something that doesn’t make your stomach churn like some of the wild crypto rides, this just might soothe those nerves. Or maybe it’s just a slick way to...

Continue Reading
Fluence Faces Legal Battle Amid Major Stock Plunge

Updated Category News Views 55

The High Stakes for Fluence Energy Investors Well, here's a plot twist, or perhaps not for those who've been keeping an eye on the renewable energy sector. Fluence Energy (NASDAQ:FLNC), a supposed heavyweight in energy storage and renewable innovations, is tangled in a legal web over securities fraud. As of now, Fluence has been slapped with a class action lawsuit...

Continue Reading

Top 5 Most Recently Viewed Articles

Economic Impact of Trump's Trade Deal: What Comes Next?

Updated Category News Views 270

Trade Deal Analysis and Its Implications President Donald Trump’s recent trade agreement with the European Union has sparked a wave of criticism from economists across the board. The general consensus among experts is that the deal could have adverse effects on American consumers and businesses alike. Insights from Notable Economists Economist Peter Schiff shared his...

Continue Reading
Innovative Navigation Solutions from NAL Research and Partners

Updated Category News Views 369

Strategic Collaboration Enhances Maritime Navigation In an exciting partnership, NAL Research, a leader in Assured Positioning, Navigation, and Timing (APNT) solutions, has joined forces with SGM Technology AS and Tschudi Shipping Company to create innovative navigation and tracking solutions tailored for the commercial maritime sector. This collaboration aims to tackle...

Continue Reading
Global Ready-Mix Concrete Market Set for Remarkable Growth

Updated Category News Views 187

Ready-mix Concrete Market Overview Ready-mix concrete (RMC) is reshaping global construction with a projected size of USD 1824.29 billion by 2033, according to recent insights. In 2025, it's estimated at USD 989.25 billion, reflecting a robust compound annual growth rate (CAGR) of 8.06% from 2026 to 2033. This growth can be credited to rampant urbanization, robust...

Continue Reading
NevGold Reports Strong Antimony Recovery at Limo Butte Project

Updated Category News Views 105

Positive Metallurgical Test Results from NevGold Vancouver, British Columbia – NevGold Corp. (“NevGold” or the “Company”) (TSXV: NAU) (OTCQX: NAUFF) (Frankfurt: 5E50) is excited to share impressive results from its recent metallurgical testwork at the Limousine Butte Project. This site has gained recognition as a promising area for mining, particularly for its...

Continue Reading
Exploring Arbutus Biopharma's Financial Success and Future Ahead

Updated Category News Views 192

Arbutus Biopharma Posts Strong Financial Results Arbutus Biopharma Corporation (NASDAQ: ABUS) reported a notable total revenue of $10.7 million for the second quarter of 2025, representing a significant increase compared to previous earnings. This financial growth encompasses deferred revenue linked to the reacquisition of rights to imdusiran, an innovative treatment the...

Continue Reading